Literature DB >> 20511413

Increased inducible nitric oxide synthase and arginase II expression in heart failure: no net nitrite/nitrate production and protein S-nitrosylation.

Philipp Heusch1, Stephanie Aker, Kerstin Boengler, Elisabeth Deindl, Anita van de Sand, Kristina Klein, Tienush Rassaf, Ina Konietzka, Adrian Sewell, Sara Menazza, Marcella Canton, Gerd Heusch, Fabio Di Lisa, Rainer Schulz.   

Abstract

Our objective was to address the balance of inducible nitric oxide (NO) synthase (iNOS) and arginase and their contribution to contractile dysfunction in heart failure (HF). Excessive NO formation is thought to contribute to contractile dysfunction; in macrophages, increased iNOS expression is associated with increased arginase expression, which competes with iNOS for arginine. With substrate limitation, iNOS may become uncoupled and produce reactive oxygen species (ROS). In rabbits, HF was induced by left ventricular (LV) pacing (400 beats/min) for 3 wk. iNOS mRNA [quantitative real-time PCR (qRT-PCR)] and protein expression (confocal microscopy) were detected, and arginase II expression was quantified with Western blot; serum arginine and myocardial nitrite and nitrate concentrations were determined by chemiluminescence, and protein S-nitrosylation with Western blot. Superoxide anions were quantified with dihydroethidine staining. HF rabbits had increased LV end-diastolic diameter [20.0 + or - 0.5 (SE) vs. 17.2 + or - 0.3 mm in sham] and decreased systolic fractional shortening (11.1 + or - 1.4 vs. 30.6 + or - 0.7% in sham; both P < 0.05). Myocardial iNOS mRNA and protein expression were increased, however, not associated with increased myocardial nitrite or nitrate concentrations or protein S-nitrosylation. The serum arginine concentration was decreased (124.3 + or - 5.6 vs. 155.4 + or - 12.0 micromol/l in sham; P < 0.05) at a time when cardiac arginase II expression was increased (0.06 + or - 0.01 vs. 0.02 + or - 0.01 arbitrary units in sham; P < 0.05). Inhibition of iNOS with 1400W attenuated superoxide anion formation and contractile dysfunction in failing hearts. Concomitant increases in iNOS and arginase expression result in unchanged NO species and protein S-nitrosylation; with substrate limitation, uncoupled iNOS produces superoxide anions and contributes to contractile dysfunction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20511413     DOI: 10.1152/ajpheart.01034.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  20 in total

1.  Upregulation of arginase activity contributes to intracellular ROS production induced by high glucose in H9c2 cells.

Authors:  Lu Zhou; Chuan-Bo Sun; Chao Liu; Yue Fan; Hong-Yi Zhu; Xiao-Wei Wu; Liang Hu; Qing-Ping Li
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  High fat feeding impairs endothelin-1 mediated vasoconstriction through increased iNOS-derived nitric oxide.

Authors:  K L Sweazea; B R Walker
Journal:  Horm Metab Res       Date:  2011-03-29       Impact factor: 2.936

3.  Sex Difference in Oxidative Stress Parameters in Spinal Cord of Rats with Experimental Autoimmune Encephalomyelitis: Relation to Neurological Deficit.

Authors:  Mirjana Dimitrijević; Jelena Kotur-Stevuljević; Zorica Stojić-Vukanić; Ivana Vujnović; Ivan Pilipović; Mirjana Nacka-Aleksić; Gordana Leposavić
Journal:  Neurochem Res       Date:  2016-11-03       Impact factor: 3.996

Review 4.  Cardiac NO signalling in the metabolic syndrome.

Authors:  O Pechánová; Z V Varga; M Cebová; Z Giricz; P Pacher; P Ferdinandy
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

5.  Leukocyte iNOS is required for inflammation and pathological remodeling in ischemic heart failure.

Authors:  Justin R Kingery; Tariq Hamid; Robert K Lewis; Mohamed Ameen Ismahil; Shyam S Bansal; Gregg Rokosh; Tim M Townes; Suzanne T Ildstad; Steven P Jones; Sumanth D Prabhu
Journal:  Basic Res Cardiol       Date:  2017-02-25       Impact factor: 17.165

6.  Regulation of Inducible Nitric Oxide Synthase (iNOS) and its Potential Role in Insulin Resistance, Diabetes and Heart Failure.

Authors:  Sanja S Soskić; Branislava D Dobutović; Emina M Sudar; Milan M Obradović; Dragana M Nikolić; Jelena D Djordjevic; Djordje J Radak; Dimitri P Mikhailidis; Esma R Isenović
Journal:  Open Cardiovasc Med J       Date:  2011-07-07

Review 7.  Arginase induction and activation during ischemia and reperfusion and functional consequences for the heart.

Authors:  Klaus-Dieter Schlüter; Rainer Schulz; Rolf Schreckenberg
Journal:  Front Physiol       Date:  2015-03-11       Impact factor: 4.566

8.  Arginase inhibition augments nitric oxide production and facilitates left ventricular systolic function in doxorubicin-induced cardiomyopathy in mice.

Authors:  Takumi Toya; Daihiko Hakuno; Yasunaga Shiraishi; Takehiko Kujiraoka; Takeshi Adachi
Journal:  Physiol Rep       Date:  2014-09-28

9.  TRiC/CCT chaperonins are essential for maintaining myofibril organization, cardiac physiological rhythm, and lifespan.

Authors:  Girish C Melkani; Shruti Bhide; Andrew Han; Jay Vyas; Catherine Livelo; Rolf Bodmer; Sanford I Bernstein
Journal:  FEBS Lett       Date:  2017-10-10       Impact factor: 4.124

10.  CardioNet: a human metabolic network suited for the study of cardiomyocyte metabolism.

Authors:  Anja Karlstädt; Daniela Fliegner; Georgios Kararigas; Hugo Sanchez Ruderisch; Vera Regitz-Zagrosek; Hermann-Georg Holzhütter
Journal:  BMC Syst Biol       Date:  2012-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.